The pandemic's impact on non-COVID research
Non-COVID-19 research has taken a back seat during the pandemic as scientists everywhere scramble to better understand the Sars-CoV-2 virus and develop therapies and vaccines. But it remains important for the scientific community to strongly advocate for sustained investment into non-COVID research. Share your experiences and perspectives to help inform our policy solutions to sustain non-COVID-19 research.
Speakers
![David Kennedy](/getmedia/6a3c3a2b-76e9-402f-b7e5-7727580e625e/300x300-David-Kennedy.jpg)
David Kennedy
Vice president and director of costing policies, Council on Governmental Relations
![Melur K. Ramasubramanian](/getmedia/69890913-4091-4766-a743-12a1322f7ecd/300x300-Melur-Ramasubramanian.jpg)
Melur K. Ramasubramanian
Vice president for research, University of Virginia
![Nick Rhind](/getmedia/d26e5670-eb92-4608-8906-a481ce6b8126/300x300-nick-rhind_1.jpg)
Nick Rhind
Professor, University Massachusetts Medical School
Who should watch
- Researchers focused on non-COVID research
- Heads of labs
Learning objectives
Understand the experience of shutting down and ramping up non-COVID research, funding for non-COVID research, challenges and obstacles to restarting non-COVID research.